Vitexin induces apoptosis and enhances daunorubicin efficacy in acute leukemia via modulation of the HIF-1α/Bcl-2/caspase-3 pathway
Chutiphong Jirawatpraphakorn, Dalina Tanyong, Attasak Jaree, Weerapat Owattanapanich · 2025
Read Vitexin induces apoptosis and enhances daunorubicin efficacy in acute leukemia via modulation of the HIF-1α/Bcl-2/caspase-3 pathway by Chutiphong Jirawatpraphakorn, Dalina Tanyong, Attasak Jaree, Weerapat Owattanapanich (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12827246.txt.
Description
A plant compound from buckwheat kin can push leukemia cells to kill themselves, and make a standard drug hit harder. Chutiphong Jirawatpraphakorn and three co-authors tested vitexin in 2025 on two cell lines and on marrow cells from patients. The compound cut cell life by dose and time, while sparing sound blood cells. Mixed with the drug daunorubicin, the pair beat either alone by the mix math.
The path runs through a low-air sensor that shields cancer cells: vitexin turned it down and let a death enzyme rise. In patient cells the mix drove the highest death share of any arm. The team back vitexin as a side help for a hard cancer, with beast tests owed for dose and safety. Its soft touch on sound cells is the draw.
Catalog record
| CREATOR | Chutiphong Jirawatpraphakorn, Dalina Tanyong, Attasak Jaree, Weerapat Owattanapanich |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |